For My Lung Health, the joint American Thoracic Society and American College of Chest Physicians (CHEST) campaign, is the winner of this year’s Pharmaceutical Executive APEX Awards in the respiratory category. The campaign, made possible by an educational grant from GlaxoSmithKline with additional support from Boehringer Ingelheim Pharmaceuticals, Inc., was launched in response to COVID-19.
"These mandates, this is not about science," the Republican governor said during a press conference in Alachua County. "Because if it was about science, you would recognize the infection conferred immunity."
Today, the Food and Drug Administration issued decisions on new tobacco product applications, addressing the over 6 million unique products and flavor variations submitted for agency review. Missing from the FDA’s announcement was a decision on a company that has the largest e-cigarette market share – Juul.
Opening a new chapter in a long, storied history dating back to 1905, the American Thoracic Society is pleased to announce that it has completed a major rebrand which includes a new, elevated logo design and a refreshed mission statement asserting the Society’s leadership role in driving innovation in the respiratory space.
Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The ATS Research Program today announced two new grant opportunities made possible by the American Lung Association/ATS/CHEST Foundation Respiratory Health Equity Research Award. Each grant provides $100,000 in funding per year for two years.
The ATS Research Program and the American Lung Association have awarded Laurie Eldredge, MD, PhD, of the University of Washington/Seattle Children’s Hospital a $100,000 Partner Grant. The ATS Research Program Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
With COVID-19 case counts rising amid the spread of the Delta variant, more than 50 health care professional societies and organizations called for all health care employers to require their employees to be vaccinated against COVID-19 in a joint statement released today. These societies and organizations represent millions of workers throughout health and long-term care – from doctors and nurses to pharmacists and physician assistants, from public health workers and epidemiologists to long-term care, home care, and hospice workers.
In response to an announcement from Philip Morris International that the company has agreed to acquire Vectura, a British inhaled medicine company, American Lung Association President and CEO Harold Wimmer and American Thoracic Society President Lynn Schnapp MD, ATSF shared the following statement:
The ATS Research Program is pleased to announce that William Zhang, MD, of Weill Cornell Medical Center is the recipient of the 2020-2021 ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome. The $50,000 award will support Dr. Zhang’s research study, “Hyperferritinemia in COVID-19 ARDS: Friend or Foe?”
The ATS Research Program and the chILD Foundation have awarded Anthony Shum, MD, of the University of California, San Francisco $80,000. The award will support Dr. Shum’s research project, “Defining the pathogenesis of childhood ILD in COPA syndrome.”
Today, the ATS Research Program announced that Jessica Blackburn, PhD, of Vanderbilt University has been awarded the ATS/GSK Research Grant in Obstructive Lung Disease. The grant was funded through GlaxoSmithKline (GSK) support of the ATS Research Program.
The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.
June 08, 2021 – Christopher Chesley, MD, of the University of Pennsylvania has been named the 2021 ATS Fellowship in Health Equality Award winner for his project “Determining disparities in care quality for patients with acute respiratory failure and sepsis: the role of hospital-wide capacity strain.”
Neelima Navuluri, MD, of Duke University has been awarded the ATS/Mallinckrodt Research Grant on COVID-19 in Underrepresented Minorities.
Seniors who are enrolled in both Medicare and Medicaid are at risk for experiencing greater worsening of functional status following ICU hospitalization, according to research presented at the ATS 2021 International Conference.
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Environmental tobacco smoke exposure in utero and during early childhood—especially secondhand smoke—is associated with decreased childhood lung function, according to research presented at the ATS 2021 International Conference.
Approximately two-fifths of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) have limited access to pulmonary rehabilitation services due to their distance from rehab centers, according to research presented at the ATS 2021 International Conference. More than 24 million U.S. adults suffer from COPD, a smoking related disease.
Some patients with coronary artery disease and non-sleepy obstructive sleep apnea (OSA) may be protected against serious cardiac events by CPAP therapy, according to research presented at the ATS 2021 International Conference.
The more severe a patient’s obstructive sleep apnea (OSA), the greater their risk of contracting COVID-19, according to research presented at the ATS 2021 International Conference. The study also found that the longer patients used positive airway pressure (PAP) each night, the more they lowered their COVID-19 risk.
Air quality standards recommended by the American Thoracic Society (ATS) have the potential to prevent more illness and death than standards adopted by the U.S. Environmental Protection Agency (EPA), according to research presented at the ATS 2021 International Conference.
The COVID-19 pandemic has, and will continue to have, a tremendous impact on ICU nurses’ mental health and willingness to continue in the critical care work force, according to research presented at the ATS 2021 International Conference.
The American Thoracic Society has named Polly E. Parsons, MD, ATSF, and past president of the ATS, as the 2021 Edward Livingston Trudeau Medalist. The award was presented during the 2021 ATS International Conference.
By removing “race correction” from the interpretation of pulmonary function test (PFT) results, Black individuals were shown to have a significantly higher prevalence and severity of lung disease, according to research presented at the ATS 2021 International Conference.
Patients with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes shortness of breath and low oxygen levels because of lung scarring, have worse outcomes if they live in poor neighborhoods, according to research presented at the ATS 2021 International Conference.
A weighted “lottery” designed to increase access to the antiviral drug remdesivir during the May-July 2020 COVID-19 surge for those most affected by the coronavirus, including members of the Black, Latinx and indigenous communities, led to more equitable distribution of the badly needed medication, according to research presented at the ATS 2021 International Conference.
While vaping is thought to be a safer alternative to smoking, teens and adults who use e-cigarettes have increased odds of developing asthma and having asthma attacks, according to research presented at the ATS 2021 International Conference.
The use of e-cigarettes is associated with wheezing and shortness of breath in young adults and adolescents, even in those who don’t smoke cigarettes or marijuana, according to research presented at the ATS 2021 International Conference.
Having genetic risk variants in the ABO gene might significantly increase the chances of developing COVID-19, and other genes may also increase COVID-19 risk, according to research presented at the ATS 2021 International Conference.
Individuals with asthma who live in redlined neighborhoods have worse lung function than those in locales that excluded Black people and benefited from decades of inequitable wealth accumulation at the expense of Black communities in the United States, according to research presented at the ATS 2021 International Conference.
The American Thoracic Society is recognized for its commitment to diversity and inclusion and is respected as a powerful advocate protecting the health of the American people by encouraging increased investment in public health care. During the ATS 2021 International Conference starting May 14, respiratory imaging disruptor 4DMedical is partnering with the ATS to make better health care technologies accessible to those who need it the most.
In its latest clinical practice guideline on community-acquired pneumonia the American Thoracic Society’s guidelines panel addresses the use of nucleic acid-based testing for non-influenza viral pathogens. The guideline was published online in the May 1 issue of the American Journal of Respiratory and Critical Care Medicine. An explainer video may be viewed here.
In advance of a wildfire season projected to be among the worst, the American Thoracic Society has released a report that calls for a unified federal response to wildfires that includes investment in research on smoke exposure and forecasting, health impacts of smoke, evaluation of interventions, and a clear and coordinated communication strategy to protect public health.
(April 29, 2021) NY, NY – In a historic move, the Biden Administration announced today its decision to ban menthol cigarettes and flavored cigars. The decision comes after a protracted battle in the courts in which the tobacco industry’s aggressive marketing of menthol cigarettes was challenged by medical and public health organizations, including the American Thoracic Society.
Deborah Winter, PhD of Northwestern University has been awarded the ATS /Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis.
The claim that you don’t have to wear a mask after receiving the COVID-19 vaccine has been circulating on social media and told by conservative media pundits such as Tucker Carlson and Rep. Jim Jordan.
What can you expect at the ATS 2021 International Conference, taking place May 14-19? We’ve gone ahead and identified some “hot topics” for your consideration.
A new commentary published online in the Annals of the American Thoracic Society provides an exhaustive examination of published research that discusses whether air pollution may be linked to worse COVID-19 outcomes. The studies that the authors examined look at several potential disease mechanisms, and also at the relationship between pollution, respiratory viruses and health disparities.
An article launched today by the Forum of International Respiratory Societies (FIRS), an organization comprised of the world's leading international respiratory societies, including the American Thoracic Society, highlights COVID-19 efficacy and safety and calls for urgent equitable access in all countries.
A new study published online in the Annals of the American Thoracic Society examines if the source of physician payment for a medical opinion influences whether the physician finds that a coal miner has black lung disease. The study is the first to look at this relationship in the workers’ compensation process.
A recent opinion piece in the NY Post ignores evidence supporting the effectiveness of lockdowns.
In support of World TB Day, March 24, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, joins the World Health Organization campaign urging governments to act on the commitments made to end TB.
A new study published online in the Annals of the American Thoracic Society reveals how socioeconomic factors partially explain the increased odds that Black and Hispanic Americans have of testing positive for SARS-CoV-2, the virus that causes COVID-19.
Register today to cover the ATS 2021 International Conference and explore the ATS 2021 program before the May 14 online event launches.
A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right